PMID,Title,Journal,Year
40933463,Risk factors and long-term prognosis for colorectal strictures in ulcerative colitis.,World journal of gastroenterology,2025
40929061,Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.,Journal of Crohn's & colitis,2025
40920365,Blood proteomic signatures associated with disease activity in Inflammatory Bowel Diseases.,Journal of Crohn's & colitis,2025
40916681,"Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series.",Alimentary pharmacology & therapeutics,2025
40900639,Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive review.,Journal of Crohn's & colitis,2025
40895558,An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn's disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytes.,Frontiers in immunology,2025
40872519,Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.,"Pharmaceuticals (Basel, Switzerland)",2025
40869536,"Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023.",Journal of clinical medicine,2025
40852895,"Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.",Journal of Crohn's & colitis,2025
40845197,Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases.,Inflammatory bowel diseases,2025
40836379,Real-world efficacy of ustekinumab and vedolizumab in pediatric and young adult patients with inflammatory bowel disease.,Journal of pediatric gastroenterology and nutrition,2025
40828456,Realâ€‘world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria region.,Pharmacological reports : PR,2025
40821793,Multi-omics derivation of a core gene signature for predicting therapeutic response and characterizing immune dysregulation in inflammatory bowel disease.,Frontiers in immunology,2025
40817170,Clinical use of vedolizumab subcutaneous formulation in inflammatory bowel diseases: a review of real-world evidence.,International journal of colorectal disease,2025
40814572,Have we hit the JAK-pot? Success of selective JAK 1 inhibitor following failure of pan-JAK inhibitor in refractory pediatric ulcerative colitis.,JPGN reports,2025
40808950,The role of vitamin D deficiency and modifiable risk factors in patients with Crohn's disease.,Frontiers in immunology,2025
40806196,"Interplay of Gut Microbiota, Biologic Agents, and Postoperative Anastomotic Leakage in Inflammatory Bowel Disease: A Narrative Review.",International journal of molecular sciences,2025
40791287,Advancements in Immunomodulatory Therapies for IBD and Their Interplay With the Gut-Brain Axis: An Updated Review of Current Literature and Beyond.,Health science reports,2025
40778752,Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.,Alimentary pharmacology & therapeutics,2025
40773365,Elderly-Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment Patterns.,United European gastroenterology journal,2025
